SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-000865
Filing Date
2024-02-12
Accepted
2024-02-12 09:04:50
Documents
17
Period of Report
2024-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sunshine_8k.htm   iXBRL 8-K 28129
2 MAY 2023 WARRANT PURCHASE AGREEMENT sunshine_ex1001.htm EX-10.1 11983
3 FORM OF APRIL 2022 WARRANT PURCHASE AGREEMENT sunshine_ex1002.htm EX-10.2 12990
  Complete submission text file 0001683168-24-000865.txt   275477

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sbfm-20240211.xsd EX-101.SCH 3553
5 XBRL DEFINITION FILE sbfm-20240211_def.xml EX-101.DEF 26585
6 XBRL LABEL FILE sbfm-20240211_lab.xml EX-101.LAB 36550
7 XBRL PRESENTATION FILE sbfm-20240211_pre.xml EX-101.PRE 25209
18 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5444
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 24617591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)